Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Breakthrough Implantable Medical Devices Use Polymer Nanofabrics

By HospiMedica International staff writers
Posted on 16 Dec 2008
New implantable medical devices are being made of electrospun polymer nanofabrics, a biomaterial made of ultra-thin polymer fibers, with properties that mimic those of human tissues and organs.

Among the new products benefiting from the process is the NovaMesh Ventral Hernia Mesh, which features improved resistance to tissue adhesion on the visceral-facing surface, while promoting excellent tissue ingrowth on the fascial surface. More...
The electrospun nanofabric used to manufacture the mesh results in near-perfect flatness, no shrinkage, and virtually no creasing or kinking following tight rolling and unrolling of the mesh. The biomimetic properties of the fabric allow easy handling and laparoscopic insertion, and all sizes can fit through a trocar.

Another innovation is the AVflo vascular access graft used for hemodialysis, a self-sealing vascular access graft that enables unobstructed blood flow, allows for dialysis within 24-48 hours after implantation and a self-sealing feature within less than five minutes of withdrawal of the dialysis needles. The graft is also simple to implant and to suture to blood vessels, as the needle punctures and suture holes seal rapidly. AVflo is also strong enough to withstand the pressure of blood flow, yet thin enough for blood flow to be easily felt through it. Both the NovaMesh Ventral Hernia Mesh and the AVflo vascular access graft are products of Nicast (Lod, Israel), and have receive the European Community (CE) Marking of approval.

"Nicast is one of the few companies with expertise in the use of electrospinning. The company's extensive product line is built on its many patents and various technology platforms. Other products in development at Nicast include non-metallic stents, a spinal disc device, and drug release devices," said Dr. Jacob Dagan, chairman of the board of Nicast.

Discovered in the early 1900's, electrospinning is a long-known polymer processing technique that allows for the creation of non-woven fabrics made of ultra-thin polymer fibers. The material can be applied to create many products including medical devices, tissue engineering scaffolds, clothing, and filtration media. The properties of the fibers can be designed in advance and controlled to a high degree, since the fibers can be spun onto any shape using a wide range of polymers. The fibers are very thin and have a high length to diameter ratio, thereby providing a very large surface area per unit mass, so that only a small amount of material is required, and there is very little waste.

Related Links:
Nicast



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.